Northern Trust’s Codiak BioSciences, Inc. Common Stock CDAK Stock Holding History

Northern Trust’s Portfolio CDAK Stock Details CDAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-26,131	Closed	-$10.4K	–	4644
2022 Q4	$10.4K	Hold	26,131	–	–	﹤0.01%	4568
2022 Q3	$20K	Hold	26,131	–	–	﹤0.01%	4549
2022 Q2	$75K	Sell	26,131 -111,938	-81%	-$393K	﹤0.01%	4283
2022 Q1	$866K	Sell	138,069 -6,120	-4%	-$38.4K	﹤0.01%	3494
2021 Q4	$1.61M	Buy	144,189 +4,143	+3%	+$57.4K	﹤0.01%	3331
2021 Q3	$2.29M	Sell	140,046 -1,820	-1%	-$32.6K	﹤0.01%	3217
2021 Q2	$2.63M	Buy	141,866 +68,061	+92%	+$1.31M	﹤0.01%	3229
2021 Q1	$1.11M	Buy	73,805 +9,777	+15%	+$213K	﹤0.01%	3540
2020 Q4	$2.07M	Buy	+64,028	New	+$847K	﹤0.01%	3173

Other funds holding CDAK

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

UOTTAIMCU

University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Forefront Analytics West Conshohocken, Pennsylvania $110M AUM 18.54% 1-Year Est. Return

Parametrica Management Wanchai, Hong Kong $88M AUM 48.84% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust's CDAK Position: Q1 2023 in Review

Northern Trust sold out of Codiak BioSciences, Inc. Common Stock (CDAK) in Q1 2023, closing a stake of 26,131 shares — an estimated $10.4K sold.

Northern Trust first reported a position in CDAK in Q4 2020 and held it in 9 quarters. The position peaked at $2.63M in Q2 2021. 27 funds tracked by Wall St. Rank hold CDAK as of Q1 2023.

Northern Trust reported no remaining Codiak BioSciences, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Northern Trust sold 26,131 Codiak BioSciences, Inc. Common Stock shares in Q1 2023, an estimated $10.4K.
Northern Trust first reported a position in Codiak BioSciences, Inc. Common Stock in Q4 2020 and held it in 9 quarters.
Northern Trust's Codiak BioSciences, Inc. Common Stock position peaked at $2.63M in Q2 2021.
27 funds tracked by Wall St. Rank held Codiak BioSciences, Inc. Common Stock as of Q1 2023.

Based on Northern Trust's 13F filing for Q1 2023, filed 15 May 2023.